Cargando…

2021. Efficacy of Chronic Antimicrobial Suppressive Therapy in Ventricular Assist Device Infections

BACKGROUND: Ventricular assist devices (VAD) prolong life expectancy or serve as a bridge to heart transplant in end stage heart failure but are not without risks. These patients are at high risk for device-related infections with a propensity for relapse. Indications and efficacy of chronic antimic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Teran, Nicholas S, Russo, Hannah, Rizwan Sohail, M, Phe, Kady
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752638/ http://dx.doi.org/10.1093/ofid/ofac492.1645

Ejemplares similares

1587. Analysis of Breakthrough Blood Stream Infections in Left Ventricular Assist Device Recipients Managed With Chronic Antimicrobial Suppressive Therapy
por: Jandhyala, Deeksha, et al.
Publicado: (2018)

2811. Real-World Experience Utilizing Cefiderocol for Serious Multidrug Resistant Gram-Negative Infections
por: Teran, Nicholas S, et al.
Publicado: (2023)

239. Comparing Alternative Treatment Options for Stenotrophomonas maltophilia bacteremia
por: Teran, Nicholas S, et al.
Publicado: (2023)

1998. Impact of Rapid Blood Culture Identification with Real-Time Antimicrobial Stewardship (ASP) in Patients with Staphylococcus aureus (S. aureus) and Enterococcus spp. Bacteremia at a Large Academic Medical Center
por: Ryan Russo, Hannah, et al.
Publicado: (2019)

2431. Evaluation of Clinical Outcomes in Bacteremia Due to AmpC β-Lactamase Producing Organisms Stratified by Treatment
por: Carlson, Travis, et al.
Publicado: (2018)

1624. Real World Experience with Daptomycin (DAP) and Ceftaroline (CPT) Combination Therapy for Methicillin-resistant Staphylococcus aureus (MRSA) bacteremia
por: Zidaru, Andrei, et al.
Publicado: (2020)

589. Assessment of an Antiretroviral Therapy Policy in Patients with Human Immunodeficiency Virus at a Large Academic Medical Center
por: Barber, Elizabeth, et al.
Publicado: (2018)

1037. A Pharmacist-Driven 48 Hour Antibiotic Time Out Pilot at a Large Academic Medical Center
por: Carlson, Travis J, et al.
Publicado: (2019)

123. Impact of Enterococcal Bacteremia on Clinical Outcomes in Patients with Liver Cirrhosis
por: Phe, Kady, et al.
Publicado: (2019)

1825. Comparative Effectiveness of Ampicillin versus Vancomycin or Daptomycin for the Treatment of Ampicillin-Susceptible Enterococcus spp. Bloodstream Infections
por: Chua, Hubert C, et al.
Publicado: (2022)

Management of Bloodstream Infections in Left Ventricular Assist Device Recipients: To Suppress, or Not to Suppress?
por: Esquer Garrigos, Zerelda, et al.
Publicado: (2020)

200. Comparison of Clinical Outcomes among Patients Treated with Ceftriaxone 2 Grams versus 1 Gram Daily for Gram-Negative Bacteremia
por: Huynh-Phan, Ricky, et al.
Publicado: (2023)

238. Comparison of Outcomes of Patients with Gram-Negative Bacterial Left Ventricular Assist Device-Related Infections on Chronic Suppressive Antibiotic Therapy versus Patients Monitored on No Antibiotic Therapy
por: Svoronos, Petros, et al.
Publicado: (2023)

2763. Evaluating the Safety and Effectiveness of Long-term Antibiotic Suppression in Patients with Left Ventricular Assist Devices
por: Hamlin, Kelsey D, et al.
Publicado: (2023)

584. Ventricular assist device infections with Pseudomonas aeruginosa
por: Roberts, Scott C, et al.
Publicado: (2020)

2220. High burden of antibiotic exposure in left ventricular assist device (LVAD) recipients: A call for enhanced antimicrobial stewardship
por: Moore, William J, et al.
Publicado: (2023)

Epidemiology and Microbiology of First Ventricular Assist Device Infection and Their Effect on Outcomes
por: Guzman, Merilda Blanco, et al.
Publicado: (2017)

2765. Dalbavancin for challenging left ventricular assist device driveline infections
por: Doligalski, Christina, et al.
Publicado: (2023)

94. Infectious Complications of Left Ventricular Assist Devices
por: Harris, Courtney, et al.
Publicado: (2021)

1227. Candida Sternal Wound Infections After Cardiac Operations: Uncommon but Deadly
por: Seo, Jung M, et al.
Publicado: (2022)

127. Novel Treatment Approach for Left Ventricular Assist Device-related Infections
por: Yalcin, Yunus C, et al.
Publicado: (2019)

Complications in defibrillator surgery in patients with implanted ventricular assist device
por: Schroeter, Thomas, et al.
Publicado: (2015)

2625. Characteristics and Outcomes of COVID-19 in Patients with a Left Ventricular Assist Device
por: Fleites, Jorge, et al.
Publicado: (2023)

377. High Resistance and Mortality Rates in Patients With Ventricular Assist Device (VAD)-Associated Candidemia: A Need for Alternative Antifungal Strategies
por: Fong, Gary, et al.
Publicado: (2018)

Long-term Dalbavancin for Suppression of Gram-Positive Chronic Left Ventricular Assist Device Infections
por: Rowe, Sarah, et al.
Publicado: (2023)

Efficacy Of Bedside Cannulation For Percutaneous Ventricular Assist Devices
por: Patel, Nishi H., et al.
Publicado: (2022)

1180. Colonization with Multidrug-Resistant Organisms Is Associated with Subsequent Infection in the Ventricular Assist Device Population
por: Roberts, Scott C, et al.
Publicado: (2019)

2693. Epidemiology of Infections with Multidrug-Resistant Organisms in Patients with Left Ventricular Assist Devices (LVADs)
por: Axell-House, Dierdre B, et al.
Publicado: (2023)

712 Gram-negative associated Ventricular Assist Device infections
por: Patel, Ami, et al.
Publicado: (2014)

Management and Outcome of Left Ventricular Assist Device Infections in Patients Undergoing Cardiac Transplantation
por: Esquer Garrigos, Zerelda, et al.
Publicado: (2020)

2152. Epidemiology and Clinical Outcomes of Contemporary, Third-Generation Left Ventricular Assist Device (LVAD) Infections
por: Hershberger, Todd E, et al.
Publicado: (2018)

1540. Left Ventricular Assist Device Driveline Infections: Relapsed Infections and Minimum Inhibitory Concentration Changes
por: Lines, Tara, et al.
Publicado: (2018)

1176. Antibiotic Prophylaxis Strategies Prior to Left Ventricular Assist Device Implantation: A Survey of Practice
por: Mourad, Ahmad, et al.
Publicado: (2019)

2883. Comparative outcomes following Candida bloodstream infections in patients with left ventricular assist devices (LVAD)
por: Mansoor, Armaghan-e-Rehman, et al.
Publicado: (2023)

Three-year outcomes with left ventricular assist devices in country with restricted heart transplantation
por: Medressova, Assel, et al.
Publicado: (2015)

704. Evaluation of Risk Factors and Outcomes of Early Left Ventricular Assist Device Infections
por: Shealy, Stephanie, et al.
Publicado: (2020)

2427. Characterization of Early Healthcare-Associated Infections (HAI) After Implantation of Left Ventricular Assist Devices (LVAD)
por: Kling, Kendall, et al.
Publicado: (2023)

1177. A Spectrum of Infectious Complications in Continuous-Flow Ventricular Assist Devices: A Single-Center Longitudinal Cohort
por: Roberts, Scott C, et al.
Publicado: (2019)

Ventricular assist devices in pediatrics
por: Fuchs, A, et al.
Publicado: (2001)

Pediatric Ventricular Assist Device
por: Shin, Yu Rim, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_v3tt2vfbtipqbjljd1q4cm81i7